Diabetic eye disease: Best treatment options for your patients
Although a number of medical treatment advances for diabetic retinopathy (DR) and diabetic macular edema (DME) have occurred in recent years—predominantly through the introduction of the anti-vascular endothelial growth factor (VEGF) agen